Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III correction and maintenance study of subcutaneous R744 vs epoetin beta in pre-dialysis patients
jRCT2080220401Phase 3
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Carbon dioxide in anaemia, sponsored by Chugai Pharmaceutical Co., Ltd..
02
Drugs
Carbon dioxide
03
Conditions
anaemia
Beyond the preview
Go deeper on jRCT2080220401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220401.